News|Articles|December 13, 2023
Harnessing cell line engineering capabilities to enhance biotherapeutic products
Author(s)Revvity
Explore the potential of next-generation genome editing tools for driving the success of monoclonal antibodies for biotherapeutics.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B
2
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
3
PharmTech Weekly Roundup - February 6, 2026
4
Women in STEM: Early Phase Drug Development
5